Cargando…
Large Intestine Histopathology of Pegylated-Interferon-Alpha Plus Ribavirin Treated Chronic Hepatitis C Patients
Autores principales: | Pantazis, Konstantinos D., Elefsiniotis, Ioannis S., Papaioannou, Dimitrios, Brokalaki, Hero, Bonatsos, Gerasimos, Mavrogiannis, Christos |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2533104/ https://www.ncbi.nlm.nih.gov/pubmed/18795119 http://dx.doi.org/10.1155/2008/637517 |
Ejemplares similares
-
New Data concerning the Epidemiology of Hepatitis B Virus Infection in Greece
por: Pantazis, Konstantinos D., et al.
Publicado: (2008) -
Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin
por: Abbas, Zaigham, et al.
Publicado: (2013) -
Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
por: Gonçales, Fernando L, et al.
Publicado: (2010) -
Oxidative status and the response to pegylated-interferon alpha2a plus ribavirin in chronic genotype 4 HCV hepatitis
por: Ahmed, Mohammed Mahmound, et al.
Publicado: (2013) -
Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection
por: Macías, Juan, et al.
Publicado: (2015)